Sequence, Structure, and Binding Site Analysis of Kirkiin in Comparison with Ricin and Other Type 2 RIPs
Kirkiin is a new type 2 ribosome-inactivating protein (RIP) purified from the caudex of with a cytotoxicity compared to that of stenodactylin. The high toxicity of RIPs from genus plants makes them interesting tools for biotechnology and therapeutic applications, particularly in cancer therapy. The...
Saved in:
Published in: | Toxins Vol. 13; no. 12; p. 862 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
MDPI AG
03-12-2021
MDPI |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Kirkiin is a new type 2 ribosome-inactivating protein (RIP) purified from the caudex of
with a cytotoxicity compared to that of stenodactylin. The high toxicity of RIPs from
genus plants makes them interesting tools for biotechnology and therapeutic applications, particularly in cancer therapy. The complete amino acid sequence and 3D structure prediction of kirkiin are here reported. Gene sequence analysis revealed that kirkiin is encoded by a 1572 bp open reading frame, corresponding to 524 amino acid residues, without introns. The amino acid sequence analysis showed a high degree of identity with other
RIPs. The 3D structure of kirkiin preserves the overall folding of type 2 RIPs. The key amino acids of the active site, described for ricin and other RIPs, are also conserved in the kirkiin A chain. Sugar affinity studies and docking experiments revealed that both the 1α and 2γ sites of the kirkiin B chain exhibit binding activity toward lactose and D-galactose, being lower than ricin. The replacement of His246 in the kirkiin 2γ site instead of Tyr248 in ricin causes a different structure arrangement that could explain the lower sugar affinity of kirkiin with respect to ricin. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. Co-senior authorship. |
ISSN: | 2072-6651 2072-6651 |
DOI: | 10.3390/toxins13120862 |